Functionalized nanoparticles containing or coated with lumican (or lumican-derived peptides able to mimic the anti-tumor effect of lumican) could be inoculated in vivo by intravascular injection in mice melanoma models to investigate whether it could down-regulate the development of lung metastatic nodules of B16F1 melanoma cells. The gene discussed is LUM; the disease is melanoma.